Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications
US6391304B1 · kind B1 · utility
8Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2000 |
| Grant date | May 21, 2002 |
| Priority date | — |
| Expiry date | May 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is drawn is to peptides encoded by the feline immunodeficiency virus (FIV) env gene and their immunoprophylactic applications (prevention and treatment of feline immunodeficiency). Said peptides, capable of inducing a certain degree of protection against FIV infection are selected from the group consisting of: peptides containing 12 to 19 amino acids which correspond to the following: Lys-Lys-Gly-Leu-Gln-Gln-Leu-Gln-Glu-Trp-Glu-Asp-Trp-Val -Gly-Trp-Ile-Gly-Asn (SEQ ID NO:1); and peptides of not more than 50 amino acids comprising said sequence set forth by SEQ ID NO:1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.